Improving brain imaging techniques for better diagnosis of Alzheimer's disease
Spatial-frequency decompositions for enhancement of source reconstruction resolution in MEG
['FUNDING_R21'] · UNIVERSITY OF WASHINGTON · NIH-10818581
This study is working on making brain scans better so doctors can see brain activity more clearly, which could help people with conditions like Alzheimer's get more accurate diagnoses and personalized treatment plans.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10818581 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the resolution of magnetoencephalography (MEG), a non-invasive imaging technique that captures brain activity. By developing advanced algorithms, the project aims to improve the accuracy of identifying neural currents, which can provide critical insights into neurological conditions like Alzheimer's disease. The methodology involves fitting mathematical models to multi-channel data collected from the brain, allowing for a clearer understanding of brain function and its disorders. Patients may benefit from more precise diagnostics and tailored treatment plans based on improved imaging results.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.
Not a fit: Patients with neurological conditions unrelated to Alzheimer's disease may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment strategies for patients with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in enhancing imaging techniques for neurological conditions, indicating potential for success with this novel approach.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAULU, SAMU — UNIVERSITY OF WASHINGTON
- Study coordinator: TAULU, SAMU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease